ITRM Financials

Iterum Therapeutics Plc - Financial statements & key metrics

Stock Price

$0.02

Market Cap

$1.60M

EPS

$-0.72

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-24.77M

EPS (Diluted)

$-1.26

Balance Sheet Highlights

Total Assets

$44.59M

Total Liabilities

$48.68M

Shareholders Equity

Cash & Equivalents

$24.13M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-26.77M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

29.7%

Operating Margin

-19.8%

ROE

-5.6%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is ITRM revenue?

View ITRM's income statement for detailed revenue data.

Is ITRM profitable?

ITRM reported a loss of $24.77M in the most recent quarter.

What is ITRM market cap?

ITRM has a market capitalization of $1.60M, making it a small-cap stock.

Does ITRM have debt?

View ITRM's balance sheet for debt information.

What is ITRM cash flow?

Cash flow data is available in the full financial statements.